Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
- Alcalá, C.
- Quintanilla-Bordás, C.
- Gascón, F.
- Sempere, Á.P.
- Navarro, L.
- Carcelén-Gadea, M.
- Landete, L.
- Mallada, J.
- Cañizares, E.
- Belenguer, A.
- Carratalá, S.
- Domínguez, J.A.
- Pérez-Miralles, F.C.
- Gil-Perotín, S.
- Gasqué, R.
- Cubas, L.
- Castillo, J.
- Casanova, B.
ISSN: 1432-1459, 0340-5354
Argitalpen urtea: 2022
Alea: 269
Zenbakia: 7
Orrialdeak: 3676-3681
Mota: Artikulua